Use of Implantable Pump Systems for Intraarterial, Intraventricular and Intratumoral Treatment of Malignant Brain Tumors
dc.contributor.author | Chandler, William F. | en_US |
dc.contributor.author | Greenberg, Harry S. | en_US |
dc.contributor.author | Ensminger, William D. | en_US |
dc.contributor.author | Diaz, Richard F. | en_US |
dc.contributor.author | Junck, Larry | en_US |
dc.contributor.author | Hood, Terry W. | en_US |
dc.contributor.author | Gebarski, Stephen S. | en_US |
dc.contributor.author | Page, Michaelyn A. | en_US |
dc.date.accessioned | 2010-06-01T18:13:27Z | |
dc.date.available | 2010-06-01T18:13:27Z | |
dc.date.issued | 1988-06 | en_US |
dc.identifier.citation | CHANDLER, WILLIAM F.; GREENBERG, HARRY S.; ENSMINGER, WILLIAM D.; DIAZ, RICHARD F.; JUNCK, LARRY R.; HOOD, TERRY W.; GEBARSKI, STEPHEN S.; PAGE, MICHAELYN A. (1988). "Use of Implantable Pump Systems for Intraarterial, Intraventricular and Intratumoral Treatment of Malignant Brain Tumors." Annals of the New York Academy of Sciences 531(1 Neurological Applications of Implanted Drug Pumps ): 206-212. <http://hdl.handle.net/2027.42/71435> | en_US |
dc.identifier.issn | 0077-8923 | en_US |
dc.identifier.issn | 1749-6632 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/71435 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=3289457&dopt=citation | en_US |
dc.format.extent | 415901 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | 1988 The New York Academy of Sciences | en_US |
dc.title | Use of Implantable Pump Systems for Intraarterial, Intraventricular and Intratumoral Treatment of Malignant Brain Tumors | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Science (General) | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Section of Neurosurgery, University of Michigan Medical Center Ann Arbor, Michigan 48109 | en_US |
dc.contributor.affiliationum | Department of Neurology, University of Michigan Medical Center Ann Arbor, Michigan 48109 | en_US |
dc.contributor.affiliationum | Department of Internal Medicine, University of Michigan Medical Center Ann Arbor, Michigan 48109 | en_US |
dc.contributor.affiliationum | Department of Radiation Therapy, University of Michigan Medical Center Ann Arbor, Michigan 48109 | en_US |
dc.contributor.affiliationum | Department of Radiology, University of Michigan Medical Center Ann Arbor, Michigan 48109 | en_US |
dc.identifier.pmid | 3289457 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/71435/1/j.1749-6632.1988.tb31829.x.pdf | |
dc.identifier.doi | 10.1111/j.1749-6632.1988.tb31829.x | en_US |
dc.identifier.source | Annals of the New York Academy of Sciences | en_US |
dc.identifier.citedreference | Phillips, T. W., W. F. Chandler, G. W. Kindt, W. D. Ensminger, H. S. Greenberg, J. F. Seeger, K. M. Doan & J. W. Gyves. 1981. New implantable continuous administration and bolus dose intracarotid drug delivery system for the treatment of malignant gliomas. Neurosurgery 11: 213 – 218. | en_US |
dc.identifier.citedreference | Mughal, T. I., L. M. Glode, T. J. Braun, W. Klingensmith, J. M. Geier & G. W. Kindt. 1986. Phase I clinical trial of intracarotid bis-chloroethylnitrosourea (BCNU) and 2′-deoxy-5-fluorouridine (FUDR) in malignant astrocytomas. J. Neuro-Oncol. 3: 291 – 296. | en_US |
dc.identifier.citedreference | Hosino, T. 1974. Radiosensitization of brain tumors. In Modern Radiotherapy and Oncology: CNS Tumors. T. J. Deeley, Ed. 170 – 184. Butterworth. London. | en_US |
dc.identifier.citedreference | Beck, D. O. & F. H. Hochberg. 1986. Intraventricular chemotherapy for leptomeningeal carcinoma. In Cancer Chemotherapy by Infusion. J. J. Lokich, Ed. Precept Press. Chicago, IL. | en_US |
dc.identifier.citedreference | Bleyer, W. A., G. D. Poplak, A. R. Simon, et al. 1978. “ Concentration x time” methotrexate via subcutaneous reservoir: a less toxic regimen for intraventricular chemotherapy of central nervous system neoplasms. Blood 51: 835 – 842. | en_US |
dc.identifier.citedreference | Dakil, S., W. D. Ensminger, G. W. Kindt, J. Niederhuber, W. F. Chandler, H. S. Greenberg & R. Wheeler. 1981. Implanted system for intraventricular drug infusion in central nervous system tumors. Ca. Treat. Reports 65: 401 – 411. | en_US |
dc.identifier.citedreference | Harbaugh, R. E., D. W. Roberts, D. W. Combs, et al. 1984. Preliminary report: intracranial cholinergic drug infusion in patients with Alzheimer's disease. Neurosurgery 15: 514 – 518. | en_US |
dc.identifier.citedreference | Kroin, J. S. & R. D. Penn. 1982. Intracerebral chemotherapy: chronic microinfusion of cisplatin. Neurosurgery 10: 349 – 354. | en_US |
dc.identifier.citedreference | Penn, R. D., J. S. Kroin, J. E. Harris, K. M. Chiu & D. P. Braun. 1983. Chronic intratumoral chemotherapy of a rat tumor with cisplatin and fluorouracil. Appl. Neurophysiol. 46: 240 – 244. | en_US |
dc.identifier.citedreference | Bouvier, G., R. D. Penn, J. S. Kroin, R. Beique & M. J. Guerard. 1987. Direct delivery of medication into a brain tumor through multiple chronically implanted catheters. Neurosurgery 20: 286 – 291. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.